Novo Nordisk A/S (NVO) News Today $78.74 -4.33 (-5.22%) As of 01/17/2025 03:59 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period LVMH Surges Past Novo Nordisk as Arnault's Wealth Skyrockets--Is Luxury Back on Track?January 20 at 12:38 PM | uk.finance.yahoo.comNovo Nordisk A/S (NYSE:NVO) Shares Down 5.2% - What's Next?Novo Nordisk A/S (NYSE:NVO) Trading Down 5.2% - Here's WhyJanuary 20 at 12:09 PM | marketbeat.comNovo Nordisk A/S - share repurchase programmeJanuary 20 at 9:32 AM | globenewswire.comEldred Rock Partners LLC Sells 15,323 Shares of Novo Nordisk A/S (NYSE:NVO)Eldred Rock Partners LLC lessened its position in shares of Novo Nordisk A/S (NYSE:NVO - Free Report) by 16.8% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 75,851 shares of the company's stock after selling 15,323 shareJanuary 20 at 6:13 AM | marketbeat.comJim Cramer’s Comments on Novo Nordisk A/S (NVO) Surrounded Its Weight Loss Drugs Being Picked For Medicare Price NegotiationsJanuary 19 at 9:32 PM | msn.comRenaissance Investment Group LLC Sells 12,748 Shares of Novo Nordisk A/S (NYSE:NVO)Renaissance Investment Group LLC decreased its holdings in Novo Nordisk A/S (NYSE:NVO - Free Report) by 30.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 28,825 shares of the company's stock after selliJanuary 19 at 8:36 AM | marketbeat.comSanibel Captiva Trust Company Inc. Increases Stake in Novo Nordisk A/S (NYSE:NVO)Sanibel Captiva Trust Company Inc. raised its holdings in Novo Nordisk A/S (NYSE:NVO - Free Report) by 73.1% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 15,568 shares of the company's stock after buying an additional 6,57January 19 at 5:18 AM | marketbeat.com4,440 Shares in Novo Nordisk A/S (NYSE:NVO) Bought by Sax Wealth Advisors LLCSax Wealth Advisors LLC acquired a new stake in Novo Nordisk A/S (NYSE:NVO - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 4,440 shares of the company's stock, valued at approximately $382,000. Other larJanuary 19 at 4:49 AM | marketbeat.comNovo Nordisk A/S (NYSE:NVO) Trading Down 4.6% - Should You Sell?Novo Nordisk A/S (NYSE:NVO) Trading Down 4.6% - What's Next?January 19 at 3:59 AM | marketbeat.comWhy Did Novo Nordisk (NVO) Go Down on Friday?January 18 at 8:42 PM | msn.comNovo Nordisk’s Semaglutide 7.2mg s.c. achieved 21% weight loss in STEP UP trialJanuary 18 at 11:45 AM | markets.businessinsider.comNovo Nordisk A/S (NYSE:NVO) Shares Sold by Shikiar Asset Management Inc.Shikiar Asset Management Inc. lowered its position in shares of Novo Nordisk A/S (NYSE:NVO - Free Report) by 13.6% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 96,159 shares of the company's stock after selling 15,085 sJanuary 18 at 8:27 AM | marketbeat.comNovo Nordisk A/S (NYSE:NVO) Shares Sold by Atwater Malick LLCAtwater Malick LLC decreased its holdings in Novo Nordisk A/S (NYSE:NVO - Free Report) by 2.8% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 162,228 shares of the company's stock after selling 4,604 shares during the qJanuary 18 at 7:52 AM | marketbeat.comWealthcare Advisory Partners LLC Purchases 10,839 Shares of Novo Nordisk A/S (NYSE:NVO)Wealthcare Advisory Partners LLC increased its position in Novo Nordisk A/S (NYSE:NVO - Free Report) by 74.3% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 25,425 shares of the company's stock after acquiring an additioJanuary 18 at 5:36 AM | marketbeat.comIs Novo Nordisk Stock a Buy?January 18 at 5:32 AM | fool.comNovo Nordisk A/S (NYSE:NVO) Short Interest UpdateNovo Nordisk A/S (NYSE:NVO - Get Free Report) was the recipient of a large increase in short interest during the month of December. As of December 31st, there was short interest totalling 8,300,000 shares, an increase of 76.6% from the December 15th total of 4,700,000 shares. Based on an average daily volume of 6,450,000 shares, the days-to-cover ratio is presently 1.3 days.January 17 at 9:25 PM | marketbeat.comNovo Nordisk’s Wegovy Achieves Weight-Loss of 20.7% at Higher Dose, Study SaysJanuary 17 at 8:12 PM | msn.comNovo Nordisk stock prices drop after Biden lists Ozempic for price negotiationsJanuary 17 at 8:12 PM | msn.comArgus Research Remains a Buy on Novo Nordisk (NVO)January 17 at 8:12 PM | markets.businessinsider.comNovo Nordisk’s Strategic Acquisition of Catalent: Short-term Challenges but Long-term Growth Potential with a Buy RecommendationJanuary 17 at 8:12 PM | markets.businessinsider.comNovo Nordisk's Ozempic & Wegovy in 2027 Medicare price talksJanuary 17 at 8:12 PM | finance.yahoo.comNovo Nordisk's stock down 4% as the Feds get ready for a second round of drug price negotiationsJanuary 17 at 8:12 PM | msn.comExplainer: What Wegovy's inclusion in Medicare price negotiation means for patients, companyJanuary 17 at 2:30 PM | reuters.comWhy Viking Therapeutics Stock Popped, but Novo Nordisk and Hims & Hers Health Dropped TodayJanuary 17 at 11:37 AM | fool.comNovo Nordisk shares fall after Ozempic, Wegovy selected for Medicare price negotiationsJanuary 17 at 11:19 AM | proactiveinvestors.comNovo Nordisk A/S (NYSE:NVO) Shares Sold by Procyon Advisors LLCProcyon Advisors LLC lessened its stake in Novo Nordisk A/S (NYSE:NVO - Free Report) by 12.8% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 55,471 shares of the company's stock after sellingJanuary 17 at 9:28 AM | marketbeat.comTripling Wegovy dosage leads to more weight loss, Novo Nordisk trial showsJanuary 17 at 9:09 AM | marketwatch.comChannel Wealth LLC Sells 7,934 Shares of Novo Nordisk A/S (NYSE:NVO)Channel Wealth LLC lessened its holdings in Novo Nordisk A/S (NYSE:NVO - Free Report) by 13.8% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 49,419 shares of the company's stock after selling 7,934 shares during the period.January 17 at 8:17 AM | marketbeat.comUS targets Novo Nordisk's Ozempic and Wegovy for Medicare price talksJanuary 17 at 8:05 AM | reuters.comNovo Nordisk says high-dose semaglutide trial shows 20.7% weight lossJanuary 17 at 7:22 AM | reuters.comNovo Nordisk A/S: Semaglutide 7.2 mg s.c. achieved 20.7% weight loss in the STEP UP obesity trial, and 18.7% regardless of treatment adherenceJanuary 17 at 7:11 AM | globenewswire.comWerlinich Asset Management LLC Invests $1.06 Million in Novo Nordisk A/S (NYSE:NVO)Werlinich Asset Management LLC bought a new position in shares of Novo Nordisk A/S (NYSE:NVO - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 12,305 shares of the company's stock, valued aJanuary 17 at 7:04 AM | marketbeat.comCarnegie Investment Counsel Sells 14,949 Shares of Novo Nordisk A/S (NYSE:NVO)Carnegie Investment Counsel decreased its position in Novo Nordisk A/S (NYSE:NVO - Free Report) by 7.0% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 198,545 shares of the company's stock after selling 14,949 sharesJanuary 17 at 5:51 AM | marketbeat.comNovo Nordisk A/S (NYSE:NVO) Reaches New 1-Year Low - Here's What HappenedNovo Nordisk A/S (NYSE:NVO) Hits New 1-Year Low - What's Next?January 17 at 5:46 AM | marketbeat.comNovo Nordisk A/S (NVO) Price Prediction and Forecast 2025-2030January 16, 2025 | 247wallst.comNovo Nordisk, other companies to meet Danish prime minister following Trump's Greenland threatJanuary 16, 2025 | msn.comNovo Nordisk, other firms meet Danish PM to discuss Trump tariff threatsJanuary 16, 2025 | reuters.comNovo Nordisk A/S Target of Unusually High Options Trading (NYSE:NVO)Novo Nordisk A/S (NYSE:NVO - Get Free Report) was the target of some unusual options trading on Thursday. Stock traders purchased 58,638 put options on the company. This is an increase of approximately 58% compared to the typical daily volume of 37,048 put options.January 16, 2025 | marketbeat.comNovo Nordisk A/S (NYSE:NVO) Shares Gap Down - What's Next?Novo Nordisk A/S (NYSE:NVO) Shares Gap Down - Should You Sell?January 16, 2025 | marketbeat.com3,274 Shares in Novo Nordisk A/S (NYSE:NVO) Acquired by StrongBox Wealth LLCStrongBox Wealth LLC acquired a new position in shares of Novo Nordisk A/S (NYSE:NVO - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 3,274 shares of the company's stock, valued at approJanuary 16, 2025 | marketbeat.comSendero Wealth Management LLC Has $3.99 Million Stake in Novo Nordisk A/S (NYSE:NVO)Sendero Wealth Management LLC boosted its holdings in Novo Nordisk A/S (NYSE:NVO - Free Report) by 35.4% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 46,413 shares of the company's stock after purchasing an additiJanuary 16, 2025 | marketbeat.comSawyer & Company Inc Invests $4.96 Million in Novo Nordisk A/S (NYSE:NVO)Sawyer & Company Inc bought a new position in shares of Novo Nordisk A/S (NYSE:NVO - Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 57,691 shares of the company's stock, valued at approximately $4,963,00January 16, 2025 | marketbeat.comPark Avenue Securities LLC Buys 7,103 Shares of Novo Nordisk A/S (NYSE:NVO)Park Avenue Securities LLC grew its stake in Novo Nordisk A/S (NYSE:NVO - Free Report) by 7.4% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 102,657 shares of the company's stock after acquiring an additioJanuary 16, 2025 | marketbeat.comPines Wealth Management LLC Invests $331,000 in Novo Nordisk A/S (NYSE:NVO)Pines Wealth Management LLC acquired a new stake in Novo Nordisk A/S (NYSE:NVO - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 3,833 shares of the company's stock, valued at approximately $331,000. Several othJanuary 16, 2025 | marketbeat.comSeaCrest Wealth Management LLC Sells 5,947 Shares of Novo Nordisk A/S (NYSE:NVO)SeaCrest Wealth Management LLC lowered its position in shares of Novo Nordisk A/S (NYSE:NVO - Free Report) by 34.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 11,516 shares of the company's stockJanuary 16, 2025 | marketbeat.comNovo Nordisk: From Peak Performance To Needing A Booster ShotJanuary 15, 2025 | seekingalpha.comNovo Nordisk A/S (NVO) Price Prediction and Forecast 2025-2030January 15, 2025 | 247wallst.comNovo Nordisk (0QIU) Receives a Hold from BernsteinJanuary 15, 2025 | markets.businessinsider.comNovo Nordisk's valuation now more attractive: BernsteinJanuary 15, 2025 | investing.comWolff Wiese Magana LLC Buys 3,042 Shares of Novo Nordisk A/S (NYSE:NVO)Wolff Wiese Magana LLC lifted its stake in shares of Novo Nordisk A/S (NYSE:NVO - Free Report) by 25,350.0% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 3,054 shares of the company's stock after acquiring an additional 3,January 15, 2025 | marketbeat.com Get Novo Nordisk A/S News Delivered to You Automatically Sign up to receive the latest news and ratings for NVO and its competitors with MarketBeat's FREE daily newsletter. Email Address NVO Media Mentions By Week NVO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NVO News Sentiment▼0.570.44▲Average Medical News Sentiment NVO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NVO Articles This Week▼6029▲NVO Articles Average Week Get Novo Nordisk A/S News Delivered to You Automatically Sign up to receive the latest news and ratings for NVO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AstraZeneca News Today Novartis News Today Sanofi News Today GSK News Today Takeda Pharmaceutical News Today argenx News Today BioNTech News Today Teva Pharmaceutical Industries News Today BeiGene News Today Summit Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:NVO) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredWarren Buffett Bets $40 Billion—You Can Get in for $20I call it "The Last Retirement Stock You'll Ever Need." Warren Buffett himself owns $40 billion of stock in...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredTrump’s Inauguration Shocker: “Move Your Cash Now”Just in the first week after Trump's win, many stocks jumped by double and even triple digits. But now he's...InvestorPlace | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novo Nordisk A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share Novo Nordisk A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.